Answers are grounded in this paper and cite their sources.
Introduction Atherosclerotic cardiovascular disease (CVD) is more prevalent in people with HIV-1 than in people without HIV, despite effective antiretroviral therapy (ART). The underlying reasons remain unclear. Chronic inflammation, which damages vascular endothelium and promotes plaque formation, is a major contributor to atherosclerosis. Methods In this cross-sectional, exploratory study, we investigated associations among the HIV-1 reservoir, inflammation, and subclinical atherosclerosis in men with HIV-1 (MWH) in the Pittsburgh Clinical Research Site of the Multicenter AIDS Cohort Study–Women’s Interagency HIV Study Combined Cohort Study (MWCCS). Participants had undergone cardiovascular imaging studies [ultrasound and computed tomography (CT)] and were categorized based on carotid artery ultrasound-based CVD risk stratification (age-adjusted intima-media thickness and presence of focal plaque). Results We report that MWH with greater CVD risk had higher levels of intact HIV-1 provirus. Moreover, matrix metalloproteinase 9 levels were positively associated with subclinical atherosclerosis. Single-cell RNA sequencing analysis of peripheral blood immune cells showed enrichment of MTORC1, non-canonical NF-kB, senescence-associated, monocyte state 1, and HIV-1-associated transcriptional programs in monocytes, and enrichment of interferon signaling in T cells in the high-risk carotid ultrasound group. Conclusion A higher intact HIV-1 proviral burden in this cross-sectional cohort showed associations with subclinical atherosclerosis, as well as inflammatory and senescence-associated transcriptional programs in circulating immune cells.
No takes yet. Share an insight, caveat, or question.
Ashimkhanova et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: